Phase 3 Congenital Heart Disease in Children Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
HypoxiaNeurodevelopmental DisordersCongenital Heart Disease in Children+1 more
University of Utah150 enrolled5 locationsNCT05767385
Recruiting
Phase 3
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Congenital Heart Disease in ChildrenNeuroprotection
dr. M.J.N.L. Benders236 enrolled4 locationsNCT04217421